TheSojitz Corporation (“Sojitz”) has signed a memorandum of understanding with HIROTSU Bioscience Inc. (“HIROTSU”), a developer and provider of N-NOSE®, a primary cancer screening test offering early cancer detection, the WHO Foundation (“WHO Foundation”), OurCrowd, a…
Modivcare Inc. (the “Company” or “Modivcare”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that…
The Masimo Corporation (“Masimo” or the “Company”) (Nasdaq: MASI) Board of Directors today issued a letter to stockholders in connection with its definitive proxy materials filed on May 24, 2023,…
CalmWave, the company leveraging artificial intelligence (AI) to bring Operations Health to hospitals, today announced it has won the prestigious Best UX Design at the 2023 GeekWire Awards. CalmWave uses…
The global revenue cycle management market value was USD 121.8 billion in 2022, driven by the increasing volume of patient data across the globe. The market size is anticipated to…
CDW Corporation (Nasdaq: CDW), a leading multi-brand provider of information technology solutions to business, government, education and healthcare customers in the United States, the United Kingdom and Canada, today announced…
a leading digital medicine company, today announced topline results of the STARS-ADHD-Adult clinical trial evaluating the efficacy and safety of EndeavorRxⓇ (AKL-T01) in adults with attention-deficit/hyperactivity disorder (ADHD). STARS-ADHD-Adult was designed…
Henry Schein, Inc. (Nasdaq: HSIC) today kicks off THRIVELIVE™ 2023, an annual event that provides a comprehensive educational experience that offers every member of dental teams the opportunity to learn,…
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Unipath Specialty Laboratory Limited, one of the leading diagnostic…
The global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the publication of a study “Cost-Effectiveness of a Real-Time Continuous Glucose Monitoring System Versus Self-Monitoring…
Vesigen Therapeutics, Inc., a biotechnology company developing a novel non-viral delivery platform for gene editors, RNA, and protein-based therapeutics, today announced eight data presentations at the American Society of Gene…
A techbio company pioneering applications of artificial intelligence to engineering AAV capsids that can expand the potential of genetic medicine, today announced a Dyno Scientific Symposium and the presentation of…
